CLINICAL AND ECONOMIC BENEFITS OF ADJUVANTED AND HIGH-DOSE INFLUENZA VACCINES IN THE ELDERLY IN ARGENTINA

被引：0
|
作者：
Giglio, N. [1 ]
Micone, P., V [2 ]
Mould-Quevedo, J. [3 ]
Salas, C. [4 ]
Montes, J. L. [5 ]
Uruena, A. [6 ]
机构：
[1] Hosp Ninos Dr Ricardo Gutierrez, Buenos Aires, Argentina
[2] Inst Univ CEMIC, Buenos Aires, Argentina
[3] CSL Seqirus Inc, Summit, NJ USA
[4] CSL Seqirus Argentina, Buenos Aires, Argentina
[5] CSL Seqirus Argentina, Munro, Argentina
[6] SALUD Univ, Buenos Aires, DF, Argentina
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE151
引用
收藏
页码：S85 / S85
页数：1
相关论文
共 50 条
  • [1] The clinical and economic value of enhanced influenza vaccines for the elderly in Argentina
    Uruena, Analia
    Micone, Paula
    Mould-Quevedo, Joaquin
    Saenz, Carolina
    Delgado, Micaela
    Montes, Jose Luis
    Giglio, Norberto
    VACCINE: X, 2024, 21
  • [2] Cost-Effectiveness and Burden of Disease for Adjuvanted Quadrivalent Influenza Vaccines Compared to High-Dose Quadrivalent Influenza Vaccines in Elderly Patients in Spain
    Ruiz-Aragon, Jesus
    Marquez-Pelaez, Sergio
    Gani, Ray
    Alvarez, Piedad
    Guerrero-Luduena, Richard
    VACCINES, 2022, 10 (02)
  • [3] Immunogenicity of adjuvanted versus high-dose inactivated influenza vaccines in older adults: a randomized clinical trial
    Kenneth E. Schmader
    Christine K. Liu
    Brendan Flannery
    Wes Rountree
    Heidi Auerbach
    Elizabeth D. Barnett
    Elizabeth P. Schlaudecker
    Christopher A. Todd
    Marek Poniewierski
    Mary A. Staat
    Theresa Harrington
    Rongxia Li
    Karen R. Broder
    Emmanuel B. Walter
    Immunity & Ageing, 20
  • [4] Immunogenicity of adjuvanted versus high-dose inactivated influenza vaccines in older adults: a randomized clinical trial
    Schmader, Kenneth E.
    Liu, Christine K.
    Flannery, Brendan
    Rountree, Wes
    Auerbach, Heidi
    Barnett, Elizabeth D.
    Schlaudecker, Elizabeth P.
    Todd, Christopher A.
    Poniewierski, Marek
    Staat, Mary A.
    Harrington, Theresa
    Li, Rongxia
    Broder, Karen R.
    Walter, Emmanuel B.
    IMMUNITY & AGEING, 2023, 20 (01)
  • [5] Comparative Safety of Adjuvanted versus High-Dose Inactivated Influenza Vaccines in Older Adults
    Liu, C.
    Schmader, K.
    Harrington, T.
    Roundtree, W.
    Auerbach, H.
    Walter, E.
    Barnett, E.
    Schlaudecker, E.
    Todd, C.
    Ponieweirski, M.
    Staadt, M.
    Wodi, P.
    Broder, K.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2020, 68 : S140 - S140
  • [6] COST-EFFECTIVENESS AND BUDGETARY IMPACT ANALYSIS OF HIGH-DOSE QUADRIVALENT INFLUENZA VACCINES FOR THE ELDERLY POPULATION IN ARGENTINA
    Espinola, N.
    Viola, Silvestrini C.
    Ivalo, S.
    Bardach, A.
    Pastori, L.
    VALUE IN HEALTH, 2024, 27 (12) : S79 - S79
  • [7] High-dose influenza vaccines make economic sense for older people
    Jit, Mark
    LANCET INFECTIOUS DISEASES, 2015, 15 (12): : 1372 - 1373
  • [8] Comparative Postmarket Safety Profile of Adjuvanted and High-Dose Influenza Vaccines in Individuals 65 Years or Older
    Pillsbury, Alexis J.
    Fathima, Parveen
    Quinn, Helen E.
    Cashman, Patrick
    Blyth, Christopher C.
    Leeb, Alan
    Macartney, Kristine K.
    JAMA NETWORK OPEN, 2020, 3 (05) : E204079
  • [9] High-dose influenza vaccination in the elderly
    Foster, Stephan L.
    Moore, W. Paul
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2010, 50 (04) : 546 - 547
  • [10] Cost-Effectiveness of Adjuvanted Influenza Vaccine Compared with Standard and High-Dose Influenza Vaccines for Persons Aged ≥50 Years in Spain
    Perez-Rubio, Alberto
    Flores, Roberto
    Aragon, Jesus Ruiz
    Sanchez, Javier
    Marquez-Pelaez, Sergio
    Alvarez, Piedad
    Muriel, Andres Osorio
    Mould-Quevedo, Joaquin
    VACCINES, 2025, 13 (03)
12345